Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France; National Cancer Registry of Ukraine, National Cancer Institute, Kyiv, Ukraine; Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.
WHO Regional Office for Europe, Copenhagen, Denmark.
Lancet Oncol. 2021 Mar;22(3):361-369. doi: 10.1016/S1470-2045(20)30674-4. Epub 2021 Feb 5.
Screening for breast cancer and cervical cancer in the newly independent states of the former Soviet Union is largely opportunistic, and countries in the region have among the highest cervical cancer incidence in the WHO European Region. We aimed to compare the stage-specific distributions and changes over time in breast cancer and cervical cancer incidence in the newly independent states of the former Soviet Union.
We collected breast cancer and cervical cancer incidence data from official statistics from Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Republic of Moldova, Russian Federation, Ukraine, and Uzbekistan for the years 2008-17 by tumour, node, metastasis (TNM) stage, and by age where population-based cancer registry data were available. We used log-linear regression to quantify the changes over time in age-standardised rates.
During the period 2013-17, more than 50% of breast cancer cases across the analysed countries, and more than 75% of breast cancer cases in Belarus, Kazakhstan, and Ukraine, were registered at stages I-II. The proportion of stage I breast cancer cases was highest in the screening age group (50-69 years) compared with other ages in Moldova and the Russian registries, but was highest in those aged 15-49 years in Georgia and Ukraine. Breast cancer stage-specific incidence rates increased over time, most prominently for stage I cancers. For cervical cancer, the proportions of cancers diagnosed at a late stage (stages III and IV) were high, particularly in Moldova and Armenia (>50%). The proportion of stage I cervical cancer cases decreased with age in all countries, whereas the proportions of late stage cancers increased with age. Stage-specific incidence rates of cervical cancer generally increased over the period 2008-17.
Our results suggest modest progress in early detection of breast cancer in the newly independent states of the former Soviet Union. The high proportions of early-stage disease in the absence of mammography screening (eg, in Belarus) provide a benchmark for what is achievable with rapid diagnosis. For cervical cancer, there is a need to tackle the high burden and unfavourable stage-specific changes over time in the region. A radical shift in national policies away from opportunistic screening toward organised, population-based, quality-assured human papillomavirus vaccination and screening programmes is urgently needed.
Union for International Cancer Control, WHO Regional Office for Europe, and Ministry of Health of Ukraine.
在前苏联独立国家中,乳腺癌和宫颈癌的筛查主要是机会性的,该地区的国家宫颈癌发病率是世卫组织欧洲区域最高的。我们旨在比较前苏联独立国家乳腺癌和宫颈癌的特定分期分布和随时间的变化。
我们通过肿瘤、节点、转移(TNM)分期和年龄收集了 2008 年至 2017 年期间来自亚美尼亚、阿塞拜疆、白俄罗斯、格鲁吉亚、哈萨克斯坦、吉尔吉斯斯坦、摩尔多瓦共和国、俄罗斯联邦、乌克兰和乌兹别克斯坦的官方统计数据,其中包括人口为基础的癌症登记数据。我们使用对数线性回归来量化随时间变化的年龄标准化率的变化。
在分析期间,超过 50%的乳腺癌病例发生在上述所有国家,超过 75%的乳腺癌病例发生在白俄罗斯、哈萨克斯坦和乌克兰,登记为 I-II 期。在摩尔多瓦和俄罗斯的登记处,筛查年龄组(50-69 岁)的 I 期乳腺癌病例比例最高,但在格鲁吉亚和乌克兰,15-49 岁年龄组的比例最高。乳腺癌特定分期的发病率随时间增加,最明显的是 I 期癌症。宫颈癌的晚期(III 和 IV 期)诊断比例较高,尤其是在摩尔多瓦和亚美尼亚(>50%)。所有国家的 I 期宫颈癌病例比例均随年龄下降,而晚期癌症比例随年龄增加。宫颈癌的特定分期发病率在 2008-2017 年期间普遍增加。
我们的结果表明,在前苏联独立国家中,乳腺癌的早期检测取得了适度进展。在没有乳房 X 线摄影筛查的情况下(例如在白俄罗斯),早期疾病的比例较高,为快速诊断提供了一个基准。对于宫颈癌,需要解决该地区发病率高和随时间变化的特定分期不利变化的问题。迫切需要从机会性筛查向有组织的、基于人群的、质量保证的人乳头瘤病毒疫苗接种和筛查计划转变国家政策。
国际癌症控制联盟、世卫组织欧洲区域办事处和乌克兰卫生部。